Congleton Jon

Chief Executive Officer

1 company

Average

Trades Analyzed

12M Win Rate

7.1%

Avg 3M Return

-3.3%

Avg 12M Return

-23.6%

Congleton Jon is a Chief Executive Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $20.4M based on current market prices.

Holdings by Company

MLYSApr 13, 2026

Current Shares689.3K

Value$20.43M

Net Activity-438,979

Bought: 10.8KSold: 449.7K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 13, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,730	$26.83	$421,979.27	-2.2%	-	-
Jan 12, 2026	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	16,236	$32.62	$529,639.60	-1.2%	-19.3%	-
Nov 11, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	200,000	$45.44	$9,088,498.87	-4.3%	-32.6%	-
Oct 13, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,100	$42.67	$644,326.87	-0.9%	-23.4%	-
Jul 11, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,884	$14.51	$230,430.78	-1.8%	+171.8%	-
Apr 11, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,319	$12.19	$186,802.95	-1.7%	+9.3%	+98.7%
Jan 13, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	18,333	$9.06	$166,082.31	-2.0%	+48.7%	+251.9%
Oct 11, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,271	$13.52	$206,433.38	-1.7%	-27.2%	+210.9%
Jul 11, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	15,746	$13.34	$210,075.26	-1.7%	+1.0%	+6.8%
Jun 20, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Executive Officer	Sell	49,313	$12.01	$592,022.00	-1.7%	-0.2%	+15.1%